Maternal Drugs: Medicare Part D Spending

• 147medicines with Part D spending (calendar year 2024)

Each number has its full source under its own list below.

1. 1Estradiol*Estradiol · $1.69 per unit$218.2 million
2. 2EstringEstradiol · $539.53 per unit$49.2 million
3. 3Estradiol (Twice Weekly)Estradiol · $5.94 per unit$30.6 million
4. 4YuvafemEstradiol · $7.05 per unit$30.4 million
5. 5Estradiol (Once Weekly)Estradiol · $10.89 per unit$18.4 million
6. 6ImvexxyEstradiol · $25.69 per unit$13.7 million
7. 7DottiEstradiol · $7.04 per unit$13.3 million
8. 8Medroxyprogesterone Acetate*Medroxyprogesterone Acetate · $11.83 per unit$8.6 million
9. 9FemringEstradiol Acetate · $753.54 per unit$7 million
10. 10CombipatchEstradiol/Norethindrone Acet · $29.89 per unit$5.4 million
11. 11Estradiol-Norethindrone AcetatEstradiol/Norethindrone Acet · $1.46 per unit$4.9 million
12. 12Climara ProEstradiol/Levonorgestrel · $61.16 per unit$3.7 million
13. 13Vivelle-DotEstradiol · $18.29 per unit$3.2 million
14. 14VagifemEstradiol · $19.97 per unit$3.1 million
15. 15ClimaraEstradiol · $13.21 per unit$3.1 million

Source: Centers for Medicare & Medicaid Services, Medicare Part D Spending by Drug, calendar year 2024. Retrieved 12 Nov 2026.

• Maternal deaths
• Prenatal care
• Births with skilled staff

• Women's health
• Neonatal
• Mental health
• Anemia
• Contraception
• Diabetes
• Hypertension
• Malaria
• Obesity
• HIV